Calton & Associates, Inc. Zai Lab LTD Transaction History

Calton & Associates, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$105.0 - $178.37 $197,610 - $335,692	-1,882 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$125.11 - $180.0 $7,881 - $11,340	-63 Reduced 3.24%	1,882 $333,000
Q1 2021 May 03, 2021	SELL	$126.27 - $191.71 $52,528 - $79,751	-416 Reduced 17.62%	1,945 $260,000
Q4 2020 Jan 25, 2021	SELL	$81.94 - $135.34 $6,882 - $11,368	-84 Reduced 3.44%	2,361 $320,000
Q3 2020 Oct 30, 2020	SELL	$73.3 - $89.48 $13,927 - $17,001	-190 Reduced 7.21%	2,445 $203,000
Q2 2020 Aug 10, 2020	BUY	$48.82 - $82.53 $128,640 - $217,466	2,635 New	2,635 $216,000

146

53M

103K

439K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.72B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.